Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$939,969
-$113,389 QoQ
Shares Held
7,440
-1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,094
of 2,266 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $57,599,993 across 10 Drug Manufacturers - General names. GILD ranks #9 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
75,730 | $19,233,148 | |
| 2 | LLY |
ELI LILLY & Co
|
9,795 | $11,748,417 | |
| 3 | MRK |
Merck & Co., Inc.
|
62,572 | $8,040,502 | |
| 4 | ABBV |
AbbVie Inc.
|
26,085 | $6,564,029 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
77,353 | $4,457,079 | |
| 6 | BIIB |
Biogen Inc.
|
12,859 | $2,778,315 | |
| 7 | PFE |
Pfizer Inc
|
75,558 | $1,819,436 | |
| 8 | AMGN |
Amgen Inc
|
4,792 | $1,735,279 |
All Filings in GILD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $939,969 | 7,440 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,053,358 | 7,558 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,096,927 | 8,937 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $981,906 | 8,846 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $965,566 | 8,709 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $878,472 | 7,840 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $752,815 | 8,150 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $656,970 | 7,836 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $395,673 | 5,767 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $227,221 | 3,102 | Shares | Sole | 2024-04-15 | |
| No filing history on record for this holder in this stock. | ||||||